Michael T. Sember

MICHAEL T. SEMBER President & CEO DOR BioPharma, Inc. Mr. Sember brings
to DOR over 30 years of broad experience working with both public and
private pharmaceutical and biotech companies in the US and Europe. Mr.
Sember has an extensive business development, operating and financial
background which includes nearly 100 licensing transactions and several
corporate acquisitions. Most of Mr. Sember’s professional career was
spent in senior executive positions with Marion Laboratories and Elan
Corporation, plc. While at Elan, Mr. Sember held the position of
Executive Vice President of Business Development and was directly
responsible for building a strategic alliance portfolio, which included
over 30 products in clinical development across several therapeutic
areas including neurology, oncology, and pain management. During this
period, he generated close to $900 million in licensing revenue during
the development of the alliance portfolio. He was also responsible for
building and managing an investment portfolio valued at approximately
$1.25 billion during his tenure at Elan. Mr. Sember has served on the
Boards of eight public and private biotech companies and on the Advisory
Boards of several venture capital firms. Most recently, Mr. Sember has
served as Managing Director of EGB Advisors LLC, a San Francisco based
consulting firm and biotech incubator.